Molecular Diagnosis of the 5q Deletion in Malignant Myeloid Disorders
The 5q-chromosome is found in a spectrum of malignant myeloid disorders (1 ). The 5q deletion is the most commonly reported deletion in the myelodysplastic syndromes (MDS) and is found in 10–l5% of patients (1 ). The 5q-chromosome occurs as a sole karyotypic abnormality in the distinct myelodysplastic syndrome the 5q-syndrome (2 ). The 5q-chromosome is also observed frequently in therapy related MDS and acute myeloid leukemia (AML) where it is typically reported together with other karyotypic abnormalities (3 ). The 5q deletton is interstitial and the breakpoints are variable. The breakpoints most frequently reported are 5q12-q14 (proximal) and 5q3l-q33 (distal) (4 ). The most commonly reported 5q deletion is the del (5 )(q13q33) (5 ). There appears to be no difference in the pattern of 5q deletion breakpoints between MDS and AML (4 , 5 ).
- Use of Antisense Oligonucleotides for Therapy: Manipulation of Apoptosis Inhibitors for Destruction of Lung Cancer Cells
- Surgical Treatment of Lung Cancer: Past And Present
- Functional Analysis of Tumor Suppressor Genes in Mice
- Metastatic Orthotopic Mouse Models of Lung Cancer
- The Use of Matrigel to Facilitate the Establishment of Human Cancer Cell Lines as Xenografts
- Utilization of Thyroid Transcription Factor-1 Immunostaining in the Diagnosis of Lung Tumors
- Racial Differences in Clinical Outcome After Prostate Cancer Treatment
- Gene Therapy for Treatment of Brain Tumors (HSV-tKIn Vivo Gene Transfer): A Case Study
- Approaches to Determine Expression of Inflammatory Cytokines
- Analysis of Transformation and Tumorigenicity Using Mouse Embryonic Fibroblast Cells